相关实验视频

Updated: Jan 17, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

热冲击蛋白70 (Hsp70) 作为在固体瘤中推进免疫治疗的目标

Khouloud Hachani¹, Mohamad Ghanem¹, A Graham Pockley²

¹Department of Otolaryngology, Head and Neck Surgery, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.

Cytokine & growth factor reviews

|September 14, 2025

概括

热冲击蛋白70 (Hsp70) 是一个关键的癌症点,作为瘤相关抗原. 针对Hsp70的疗法和生物标志物显示出对固体瘤的希望,尽管存在挑战.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

热冲击蛋白70 (Hsp70) 是一个分子伴侣,对维持蛋白质平衡至关重要.
Hsp70在癌症中过度表达,通过稳定coproteins和帮助免疫规避,促进恶性瘤.
瘤细胞的异常细胞表面和细胞外Hsp70呈现使它们与健康组织区别开来.

研究的目的:

审查Hsp70在癌症中的多方面的作用.
评估HSP70作为固体瘤中的治疗标和诊断生物标志物.
讨论目前和新兴的治疗策略和Hsp70.0.的诊断应用.

主要方法:

对Hsp70在癌症中的功能进行文献综述.
对针对膜结合和细胞外Hsp70.0.的治疗方法的分析.
评估Hsp70作为用于癌症患者分层和监测的液体生物标志物.

主要成果:

Hsp70在瘤细胞上的表面表达使其成为瘤相关抗原和免疫治疗点.
治疗策略包括小分子抑制剂,NK细胞激活,抗体,疫苗和CAR-T细胞.
细胞外Hsp70显示出作为癌症管理的液体生物标志物的潜力.

结论:

Hsp70是一种多功能点,在瘤学中具有显著的翻译潜力.
需要进一步的研究和临床试验来克服诸如非目标效应和瘤异质性等挑战.
针对Hsp70的治疗和诊断为改善癌症患者的治疗结果提供了有希望的途径.

关键词:

癌症免疫疗法癌症免疫疗法化学抗原受体 (CAR) 是一种热冲击蛋白70 (Hsp70) 是一种热冲击蛋白.液体活检液体活检瘤微环境 (TME) 是指瘤的微环境.与瘤相关的抗原 (TAA)

更多相关视频

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...